Marcela Marino de Azeredo Bastos

Marcela Marino de Azeredo Bastos

Auto-generated profile, based on publicly available information

Marcela Marino de Azeredo Bastos

Universidade de São Paulo, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Arquivos Brasileiros de Oftalmologia
Verified
Journal Article
Open access
LCLaura Goldfarb Cyrino
Laura Goldfarb Cyrino
Dillan Cunha AmaralDillan Cunha Amaral
Dillan Cunha Amaral
AJAlexandre Yamada Fujimura Júnior
Alexandre Yamada Fujimura Júnior
BPBela J. Parekh
Bela J. Parekh
MBMarcela Marino de Azeredo Bastos
Marcela Marino de Azeredo Bastos
MHMarianna Almeida Hollaender
Marianna Almeida Hollaender
The advantages and disadvantages of using perioperative subconjunctival steroid injections in dropless cataract surgery continue to be debated. A systematic review of PubMed, EMBASE, and the Cochrane Central database identified five studies-two randomized controlled trials and three non-randomized studies-encompassing 70,751 eyes. Among these, 12,319 eyes (17.4%) received subconjunctival steroid injections, while 58,432 eyes (82.6%) were managed with topical steroids. The Cochrane Collaboration's RoB 2 tool was applied for bias assessments in randomized controlled trials, and heterogeneity was assessed using the I² statistics. No statistically significant differences were found between the two groups regarding macular edema (p=0.249), visual acuity (p=0.73), or laser flare count (p=0.45). Both subconjunctival injections and topical steroids demonstrated comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. Additional research is warranted to validate these conclusions.